β cell expression of the immune checkpoint ligand PD-L1 (encoded by CD274) limits autoimmune β cell destruction in type 1 diabetes (T1D). β cell display PD-L1 not only at the cell surface but also secreted on extracellular vesicles (EVs), which bind PD-1 and restrain CD8+ T cell activation. β cell IFN signaling is an e...
Chaitra Rao, Fei Huang, Saptarshi Roy et al.· bioRxiv· 0 citations
The findings support the existence of a shared non-HLA genetic architecture that may link type 1 diabetes susceptibility to both impaired insulin secretion and insulin resistance, providing preliminary genetic evidence for their convergent pathogenic mechanisms.
Qi Fu, Ke-Yao Wang, Min Shen et al.· Diabetologia· 0 citations
A dual-targeting LNP engineering strategy that integrates high-throughput compositional screening with surface conjugation of β cell-specific targeting ligands to enable selective gene delivery to pancreatic β cells is developed and establishes a versatile platform for RNA therapeutics and gene-editing applications in...
Di Yu, Yining Zhu, A. Roca-Rivada et al.· ACS Nano· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.